Harvard Physician Questions Latest ICD Cost-Effectiveness Analysis
This article was originally published in The Gray Sheet
Executive Summary
Only a small percentage of patients with implantable cardioverter defibrillators who receive appropriate shocks actually survive long enough to make the devices cost-effective, states a leading cardiologist